Clinical Trial

A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases

Name: A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases — clinical trial record (NCT07593911)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ArchAid-002

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is an investigator-initiated, open-label, single-arm, dose-escalation and dose-expansion study to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of MTM-H-001 in adult participants with B-cell-related autoimmune diseases.

Trial Details

NCT Number	NCT07593911
Lead Sponsor	Beijing GoBroad Hospital Collaborators: MagicTime Medicine
Conditions	Systemic Lupus Erthematosus (SLE), Lupus Nephritis (LN), Multiple Sclerosis, Myasthenia Gravis (MG), IgG4-Related Diseases, Rheumatoid Arthritis (RA)
Enrollment	75 participants
Start Date	2026-06
Primary Completion	2030-11 (estimated)
Study Completion	2031-06 (estimated)
Updated on ClinicalTrials.gov	2026-05-18